triple-negative

Open Access
Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies
IOANNIS A. VOUTSADAKIS and ATHINA STRAVODIMOU

Anticancer Research March 2023, 43 (3) 967-981; DOI: https://doi.org/10.21873/anticanres.16241
You have access
A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response
TSUNEHISA NOMURA, JUNICHI KUREBAYASHI, TAKUYA MORIYA, WATARU SAITO, TAKUYA MURATA, JUN YAMAMOTO, CHIHIRO HOZUMI and ROBERT M. HOFFMAN

Anticancer Research December 2021, 41 (12) 6191-6197; DOI: https://doi.org/10.21873/anticanres.15438
You have access
Triple-Negative Breast Cancer: The Progress of Targeted Therapies and Future Tendencies
CHRISTOS DAMASKOS, ANNA GARMPI, KONSTANTINOS NIKOLETTOS, MICHAIL VAVOURAKIS, EVANGELOS DIAMANTIS, ALEXANDROS PATSOURAS, PARASKEVI FARMAKI, AFRODITI NONNI, DIMITRIOS DIMITROULIS, DIMITRIOS MANTAS, EFSTATHIOS A. ANTONIOU, NIKOS NIKOLETTOS, KONSTANTINOS KONTZOGLOU and NIKOLAOS GARMPIS

Anticancer Research October 2019, 39 (10) 5285-5296; DOI: https://doi.org/10.21873/anticanres.13722
You have access
Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy
KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, AKIMITSU YAMADA, SADATOSHI SUGAE, KAZUTAKA NARUI, DAISUKE SHIMIZU, TAKASHI CHISHIMA and ITARU ENDO

Anticancer Research July 2019, 39 (7) 3863-3869; DOI: https://doi.org/10.21873/anticanres.13536
You have access
Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models
SHUYA YANO, KIYOTO TAKEHARA, HIROYUKI KISHIMOTO, HIROSHI TAZAWA, YASUO URATA, SHUNSUKE KAGAWA, TOSHIYOSHI FUJIWARA, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research January 2017, 37 (1) 57-60;
You have access
Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells
JEEYEON LEE, JIN HYANG JUNG, YEE SOO CHAE, HO YONG PARK, WAN WOOK KIM, SOO JUNG LEE, JAE-HWAN JEONG and SEUNG HEE KANG

Anticancer Research December 2016, 36 (12) 6289-6295;
You have access
Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-β Tubulin and Non-basal Subtype
KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, KUMIKO KITA, KAZUTAKA NARUI, SADAYOSHI SUGAE, DAISUKE SHIMIZU, MIKIKO TANABE, TAKESHI SASAKI, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO

Anticancer Research February 2015, 35 (2) 907-912;
You have access
Antiproliferative and Apoptosis-inducing Activity of Nobiletin Against Three Subtypes of Human Breast Cancer Cell Lines
CHEN CHEN, MISAKI ONO, MIKAKO TAKESHIMA and SHUJI NAKANO

Anticancer Research April 2014, 34 (4) 1785-1792;
You have access
Prognostic Factors in Early-stage Triple-negative Breast Cancer: Lessons and Limits from Clinical Practice
MIRCO PISTELLI, ALESSANDRA PAGLIACCI, NICOLA BATTELLI, ALFREDO SANTINELLI, TOMMASINA BISCOTTI, ZELMIRA BALLATORE, ROSSANA BERARDI and STEFANO CASCINU

Anticancer Research June 2013, 33 (6) 2737-2742;

Main menu

User menu

Search

triple-negative